Finance

Lists
214450:KOSDAQ
PharmaResearch Co Ltd
275 000,00 KRW
-1,08%
(-3 000,00) 1D
20-ноя., 15:30:27 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214450...
Open
278 000 KRW
High
287 500 KRW
Low
273 500 KRW
Mkt. cap
2,86 трлн
Avg. vol.
99,66 миң
Volume
96,80 миң
Dividend
1,35%
Quarterly dividend
925 KRW
Ex-dividend date
2024-ж., 27-дек.
P/E ratio
18,76
52-wk high
561 000 KRW
52-wk low
208 000 KRW
EPS
14 661 KRW
Shares outstanding
10,39 млн
No. of employees
542
Open
278 000 KRW
High
287 500 KRW
Low
273 500 KRW
Mkt. cap
2,86 трлн
Avg. vol.
99,66 миң
Volume
96,80 миң
Dividend
1,35%
Quarterly dividend
925 KRW
Ex-dividend date
2024-ж., 27-дек.
P/E ratio
18,76
52-wk high
561 000 KRW
52-wk low
208 000 KRW
EPS
14 661 KRW
Shares outstanding
10,39 млн
No. of employees
542
News stories
From web sources and news partners
About PharmaResearch Co Ltd
CEOJung Sangsoo
Employees542
Founded1993
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
143,35 млд
146,10 млд
178,70 млд
171,54 млд
Cost of goods sold
33,92 млд
33,17 млд
41,16 млд
-
Cost of revenue
33,92 млд
33,17 млд
41,16 млд
-
Research and development expenses
11,80 млд
10,10 млд
13,44 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42,78 млд
42,31 млд
54,78 млд
-
Operating expense
59,58 млд
55,35 млд
71,01 млд
-
Total operating expenses
93,50 млд
88,53 млд
112,17 млд
-
Operating income
49,84 млд
57,57 млд
66,53 млд
-
Other non operating income
-615,72 млн
-9,00 млд
26,82 млд
-
EBT including unusual items
49,91 млд
68,02 млд
74,05 млд
-
EBT excluding unusual items
50,89 млд
57,57 млд
82,80 млд
-
Income tax expense
10,58 млд
19,27 млд
17,82 млд
-
Effective tax rate
21,20%
28,33%
24,07%
-
Other operating expenses
105,71 млн
540,02 млн
-212,36 млн
-
Net income
32,57 млд
47,57 млд
56,57 млд
-
Net profit margin
22,72%
32,56%
31,66%
17,46%
Earnings per share
3,05 миң
4,24 миң
4,89 миң
-
Interest and investment income
5,81 млд
9,10 млд
-
-
Interest expense
-2,75 млд
-5,23 млд
-
-
Net interest expenses
3,06 млд
3,87 млд
-
-
Depreciation and amortization charges
1,50 млд
1,55 млд
1,82 млд
-
EBITDA
53,92 млд
61,77 млд
71,04 млд
-
Gain or loss from assets sale
-8,83 млн
-
-30,23 млн
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору